MedTrace Logo

Studying Lymph Nodes in Patients With Stage II Colon Cancer

NCT00949312 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2022-03-09

No results posted yet for this study

Summary

RATIONALE: Diagnostic procedures that look for micrometastases in lymph nodes removed during surgery for colon cancer may help doctors learn the extent of disease.

PURPOSE: This phase I trial is studying lymph nodes in patients with stage II colon cancer.

Conditions

Interventions

GENETIC

RNA marker analysis of lymph node and primary tumors

GENETIC

microarray profiling of primary tumors

GENETIC

reverse transcriptase-polymerase chain reaction of lymph node specimens

OTHER

diagnostic laboratory RNA and DNA biomarker analysis of primary tumors

PROCEDURE

regional lymph node dissection

OTHER

lymph node staining for H&E and pancytokeratin IHC

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Saint John's Cancer Institute

    lead OTHER

Principal Investigators

  • Anton J. Bilchik, MD, PhD, FACS · Saint John's Cancer Institute

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00949312 on ClinicalTrials.gov